Nephrogenic Systemic Fibrosis (NSF) Exposure Injury Lawsuits
Recent News Dying for an MRI - 7 News Investigation (WSVN 7 Fox News Miami/Fort Lauderdale) NSF Injury Lawyers The lawyers and attorneys at our firm are offering free case evaluations to people suffering from Nephrogenic Systemic Fibrosis. NSF has only been seen in people with pre-existing kidney disease who have been … [Read more...]
Kidney Patients Received Gadolinium Agents
FDA Issued Warnings About NSF. Fewer kidney patients have received gadolinium contrast dyes during MR studies since the US Food & Drug Administration (FDA) first issued warnings about their association with nephrogenic systemic fibrosis (NSF) in 2006. NSF is a condition involving the formation of excess fibrous connective tissue … [Read more...]
Strengthen Gadolinium MRI Dyes Warnings
New Warnings on Gadolinium Regarding Its Association With NSF. Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA … [Read more...]
Omniscan, Magnevist and OptiMARK Associated with Most NSF Cases
Drugs Are Linked To NSF Cases. Omniscan by GE Healthcare, Magnevist by Bayer Healthcare Pharmaceuticals and Covidien’s OptiMARK are linked to the highest number of nephrogenic systemic fibrosis (NSF) cases, according the American College of Radiology. The group has advised radiologists to avoid using these three gadolinium contrast … [Read more...]
GE Failing to Report Omniscan NSF Case
Danish Agency Charged GE For Failing To Report About NSF Death. The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to Omniscan contrast dye. According … [Read more...]
Judge Omniscan Ruling Good News for Plaintiffs
Hundreds of Plaintiffs In Omniscan Lawsuits Are In a Wide Berth. Attorneys representing hundreds of plaintiffs in Omniscan lawsuits have been given a wide berth by a judge overseeing the litigation. In a 58-page procedural ruling, U.S. District Judge Dan Polster restricted important parts of GE Healthcare’s case, but said most of the … [Read more...]
GE Healthcare Advised to Restrict Omniscan in 2006
GE Healthcare Experts Restrict the Use Of Omniscan. GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, GE spent the next year … [Read more...]
Omniscan UK Libel Case Stifles Criticism, Doctor Claims
Radiologist Warn That Gadolinium Is Associated With NSF. A Danish radiologist who was among the first to warn that gadolinium contrast dyes could be associated with nephrogenic systemic fibrosis (NSF) says GE Healthcare, the maker of Omniscan, is using a libel suit in the United Kingdom (UK) to shut him up. Henrick Thomsen began … [Read more...]
NSF Lawsuit to Go to Trial in California
Gadolinium Contrast Dye NSF Lawsuits. One of the first trials involving a gadolinium contrast dye - Magnevist - and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a good indicator of how NSF plaintiffs in similar lawsuits will … [Read more...]
OptiMark, Omniscan and Magnevist Carry Higher Risk
Agent Use In People With Kidney Disease At High Risk Of NSF. OptiMark, Omniscan and Magnevist gadolinium contrast dyes appear to place people with severe kidney disease at a higher risk of nephrogenic systemic fibrosis (NSF), according to a panel of medical experts. The Food & Drug Administration (FDA) advisory panel, which met … [Read more...]
Restrict Some Gadolinium Contrast Dyes
Use of Gadolinium Contrast Dyes Should Be Restricted Because of Their Association with NSF. The use of some gadolinium contrast dyes should be restricted because of their association with nephrogenic systemic fibrosis (NSF), according to a recommendation just made by a Food & Drug Administration (FDA) advisory panel. Reuters … [Read more...]
FDA Review Gadolinium Contrast Dyes
Regulators Review Gadolinium Contrast Dyes. U.S. health regulators are set to review gadolinium contrast dyes this month. The Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee will meet on December 8 to review data from gadolinium contrast … [Read more...]
Hospital Negligent For Using Gadolinium Contrast Dyes
St. Luke's Hospital Faces Lawsuit File By Victim Of NSF. St. Luke’s Hospital in Chesterfield, Mo. faces a lawsuit filed by a victim of nephrogenic systemic fibrosis (NSF). The plaintiff was administered a gadolinium based contrast dye at St. Luke's several times starting in 2005, and was diagnosed with NSF in early 2007. NSF is … [Read more...]
Study Suggests
Link Between Gadolinium Contrast Dyes and NSF. Another study has found a strong link between the use of gadolinium contrast dyes and the development of Nephrogenic Systemic Fibrosis (NSF). According to researchers at the University of Pennsylvania in Philadelphia, patients with advanced chronic kidney disease were 27 percent more … [Read more...]
Vasovist Approved for MRA Procedures
Federal Health Regulators have approved a New Gadolinium Contrast Agent. Federal health regulators have approved a new gadolinium contrast agent for use in magnetic resonance angiography, or MRA. The Food & Drug Administration (FDA) chose to approve Epix Pharmaceutical's Vasovist Injection despite the known association between … [Read more...]
Another Study Links NSF to Gadolinium Contrast Dyes
NSF has Again Found a Strong Link Between the Condition and the Use of Gadolinium Contrast Dye. A new study of people with Nephrogenic Systemic Fibrosis (NSF) has again found a strong link between the condition and the use of gadolinium contrast dyes. The study, conducted by researchers at Vanderbilt University, concludes that … [Read more...]
Hemodialysis After MRI with Gadolinium Could Prevent NSF in Some Kidney Patients
Patients Who Undergo Hemodialysis Following Exposure to Gadolinium During an MRI May Be At Less Risk. A new study indicates that some kidney patients who undergo hemodialysis following exposure to gadolinium contrast dyes during an MRI may be at less risk of developing nephrogenic systemic fibrosis (NSF). The study, conducted by … [Read more...]
NSF Sufferer Wins Fight with Insurer
A Woman with NSF has Won a Battle with her Insurance Company. A Tennesee woman with Nephrogenic Systemic Fibrosis (NSF) has won a battle with her insurance company. After two years of litigation, a judge has ordered TennCare to pay for a treatment that might save her life. TennCare is Tennessee’s Medicaid managed care program that … [Read more...]
Information: What Is NSF / NFD
NSF / NFD Has Been Linked To The Use Of Gadolinium. NSF (Nephrogenic Systemic Fibrosis), also known as NFD (Nephrogenic Fibrosing Dermopathy) has been linked to the use of Gadolinium MRI contrast dye in people with pre-existing kidney problems. NSF or NFD first appeared in 1997. Because of it sudden appearance, some researchers … [Read more...]
Lawsuit Claims GE Omniscan Caused Nephrogenic Systemic Fibrosis
GE Omniscan has been Named in a Lawsuit Over its Gadolinium Contrast Dye. General Electric Company has been named in a lawsuit over its Omniscan gadolinium contrast dye. The lawsuit alleges that Omniscan caused a Philadelphia man to develop Nephrogenic Systemic Fibrosis (NSF), a debilitating and often fatal disease. The plaintiff in … [Read more...]
Kidney Patients Risk of Gadolinium MRI NSF Injuries
Gadolinium MRI Procedures Have The Risk Of Developing NSF. Kidney patients need to know that MRI procedures that involve the use of gadolinium contrast dyes could put them at risk of developing Nephrogenic Systemic Fibrosis (NSF). Unfortunately, there are no alternatives for gadolinium contrast dyes available at this time, and … [Read more...]
Gadolinium Used in MRI Linked to Debilitating Disease
Study Links Gadolinium Used In MRI To Debilitating Disease. Another Nephrogenic Systemic Fibrosis (NSF) study has tied the debilitating condition to Gadolinium contrast agents used in Magnetic Resonance Imaging (MRI). This latest NSF research was conducted by the Centers for Disease Control (CDC), which examined a cluster of NSF … [Read more...]
Gadolinium MRI Contrast Dye Link to NSF
Gadolinium MRI Contrast Dye Link to NSF. NSF (Nephrogenic Systemic Fibrosis), sometimes called NFD (Nephrogenic Fibrosing Dermopathy) is a rare disease that so far has affected only people with pre-existing kidney problems. In 2006, researchers discovered a direct association between NSF and the use of Gadolinium MRI contrast dyes. … [Read more...]
Injuries as a Result of Gadolinium Based Contrast Agent Injections Used During MRI Scans
FDA Request For The Addition Of Boxed Warnings About NSF. Parker Waichman LLP recently learned that the Federal Drug Administration (FDA) has notified healthcare professionals of the Agency’s request for the addition of boxed warnings and new warnings about the risk of Nephrogenic Systemic Fibrosis (NSF) for all Gadolinium based … [Read more...]
